HAI-ROBOTICS
Hai Robotics ("Hai") has joined forces in the inauguration of L'Oréal's SMART Fulfillment Center in Suzhou, China. Located inside Suzhou Industrial Park, this fulfillment center signals Hai's ongoing commitment to support its customers on every step of their warehousing journey with technical expertise, quality service and prompt delivery.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240512209916/en/
From left to right: Shengdong Xu, Chief Technology Officer (Hai Robotics); Richie Chen, Founder and Chief Executive Officer (Hai Robotics); Jean-Luc Laurans, Supply Chain Director North Asia (L'Oréal); Jakub Czaplicki, Fulfillment Factory Director North Asia (L'Oréal); Alan Liu, President of Greater China, Japan & Korea (Hai Robotics); Iris Gu, Key Accounts Manager (Hai Robotics) (Photo: Business Wire)
With an area of 46,000 square meters, this fulfillment center houses Hai's essential goods-to-person solution, HaiPick System 1, including 39 HaiPick A42 Multi-Layer Autonomous Case-handling Mobile Robots (ACR), as well as HaiPort and conveyor picking workstations. L'Oréal is now able to handle D2C (direct-to-consumer) orders with elevated flexibility, efficiency and scalability for L'Oréal, without compromising on intelligence and sustainability for its supply chain operations.
"We are delighted to be a part of L'Oréal's warehousing journey by supporting them with our ACR and goods-to-person technology. This marks a key moment in our partnership," Richie Chen, Founder and CEO of Hai Robotics said. "This new fulfillment center will facilitate supply chain transformation by improving operational efficiency, storage density and flexibility in tackling orders, ultimately elevating the experience for our customers who desire speed and convenience. We are proud to support L'Oréal in achieving their broader business objectives, and look forward to what the future has to bring."
Hai Robotics provides smart and superior ecommerce warehouse solutions for companies to address challenges in order fulfillment, error reduction, return processing etc. These solutions also enable companies to adjust operations flexibly to tackle peak season and adapt to rapid workflow changes. With Hai's automation solutions, warehouses experience increased storage density between 80%-400%, as well as enhanced outbound efficiency by 2.5 times.
The L'Oréal Suzhou SMART Fulfillment Center, equipped with superior automation technology and information systems, will be a key hub in the beauty brand's handling of D2C and B2B orders in Mainland China. It will allow L'Oréal to better support its commercial clients consisting of ecommerce platforms, offline retailers, as well as beauty salons. To learn more about our HaiPick systems, please visit https://www.hairobotics.com/products.
For more information on L’Oréal, please visit https://www.loreal.com/en/mediaroom.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240512209916/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom